An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The onset of symptoms of Alzheimer's disease can occur and worsen faster in people that also have an alcohol use disorder ...

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this ...

A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...

Together people affected by a disease that afflicts one in eight older adults in Florida, they came out to Jacksonville's ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

It was the small things at first, says Stuart Lambie. His father, Ian, would ask a question and then repeat it, minutes later ...

The Hispanic population has one of the highest rates of Alzheimer’s disease. While the population is growing, research is ...

"We are excited to have completed administering first doses to all patients enrolled in our phase 2 Alzheimer's trial,” ...

Research involving the UAB reveals the most effective way to talk to people with Alzheimer's so that their emotional response ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...